Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-03-31 00:00:00 ET · period of report 2022-03-29 · accession 0001567619-22-007808 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-03-31 | 2022-03-29+ | BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Off | S - Sale | $79.49 | -2,999 | 57.6K | -5% | -$238.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-30 | S | D | 1,381 | $79.56 | 56,257 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on February 28, 2022. |
| 2 | Common | Common Stock | 2022-03-29 | S | D | 1,618 | $79.43 | 57,638 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on February 28, 2022. |